The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells
- PMID: 1691237
- DOI: 10.1016/0022-1759(90)90210-m
The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells
Abstract
Antigen-specific T cell clones are useful reagents for studies of the fine specificity of antigen recognition and of potential therapeutic use in adoptive immunotherapy for human viral and malignant diseases. Culture methods which require antigen and APC for stimulation can be problematic for the generation and long-term growth of human virus and tumor-specific T cells. We have developed an alternative culture method using monoclonal antibodies to T cell activation molecules, CD3 and CD28, as stimulation to efficiently grow CD4+ and CD8+ antigen-specific T cells from single progenitors and expand T cell clones in long-term culture. This method alleviates the requirement for large amounts of viral or tumor antigens and MHC compatible APC to sustain the growth of virus and tumor-specific T cell clones, and, as demonstrated for CD8+ CMV-specific cytotoxic T cells, overcomes the difficulties cloning CD8+ T cells using virally infected cells as antigen-presenting cells. T cell clones generated and maintained with monoclonal antibody stimulation are rapidly expanded and retain antigen-specific responses after 3 months in culture, suggesting this approach may prove useful for growing large numbers of antigen-specific T cell clones for cellular immunotherapy.
Similar articles
-
CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.J Exp Med. 1992 Feb 1;175(2):353-60. doi: 10.1084/jem.175.2.353. J Exp Med. 1992. PMID: 1370679 Free PMC article.
-
CD30-antigen-specific targeting and activation of T cells via murine bispecific monoclonal antibodies against CD3 and CD28: potential use for the treatment of Hodgkin's lymphoma.Int J Cancer. 1993 Jul 9;54(5):820-7. doi: 10.1002/ijc.2910540517. Int J Cancer. 1993. PMID: 7686889
-
Discrete association of CD3 and CD4 molecules in T-cell stimulation acting through the autologous mixed lymphocyte reaction and the CD3/T-cell receptor complex in human autoreactive T-cell clones.Scand J Immunol. 1991 Feb;33(2):141-9. doi: 10.1111/j.1365-3083.1991.tb03744.x. Scand J Immunol. 1991. PMID: 1708160
-
The human T cell receptor: analysis with cytotoxic T cell clones.Immunol Rev. 1983;74:83-112. doi: 10.1111/j.1600-065x.1983.tb01085.x. Immunol Rev. 1983. PMID: 6195086 Review.
-
An in-vitro model for tumor immunotherapy with antibody heteroconjugates.Immunol Today. 1988 Sep;9(9):257-60. doi: 10.1016/0167-5699(88)91304-7. Immunol Today. 1988. PMID: 2978374 Review. No abstract available.
Cited by
-
Leukocyte dysfunction and reduced CTLA-4 expression are associated with perianal Crohn's disease.Clin Exp Immunol. 2024 Jun 20;217(1):78-88. doi: 10.1093/cei/uxae027. Clin Exp Immunol. 2024. PMID: 38517030
-
Immune evasion of dormant disseminated tumor cells is due to their scarcity and can be overcome by T cell immunotherapies.Cancer Cell. 2024 Jan 8;42(1):119-134.e12. doi: 10.1016/j.ccell.2023.12.011. Cancer Cell. 2024. PMID: 38194912
-
Discovery of U2AF1 neoantigens in myeloid neoplasms.J Immunother Cancer. 2023 Dec 12;11(12):e007490. doi: 10.1136/jitc-2023-007490. J Immunother Cancer. 2023. PMID: 38164756 Free PMC article.
-
Virus-Specific T-Cell Therapy for Viral Infections of the Central Nervous System: A Review.Viruses. 2023 Jul 6;15(7):1510. doi: 10.3390/v15071510. Viruses. 2023. PMID: 37515196 Free PMC article. Review.
-
Development of TCR-T cell therapy targeting mismatched HLA-DPB1 for relapsed leukemia after allogeneic transplantation.Int J Hematol. 2023 Aug;118(2):252-266. doi: 10.1007/s12185-023-03621-y. Epub 2023 Jun 13. Int J Hematol. 2023. PMID: 37310580
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
